{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:01:40Z","timestamp":1778878900853,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"30","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Korea Institute for Planning and Evaluation of Technology in Food, Agriculture, Forestry and Fisheries"},{"DOI":"10.13039\/501100003624","name":"Ministry of Agriculture, Food, and Rural Affairs","doi-asserted-by":"crossref","award":["316042-03-2-HD020"],"award-info":[{"award-number":["316042-03-2-HD020"]}],"id":[{"id":"10.13039\/501100003624","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"KHIDI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009647","name":"Ministry of Health","doi-asserted-by":"publisher","award":["HD16A1487"],"award-info":[{"award-number":["HD16A1487"]}],"id":[{"id":"10.13039\/100009647","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.vaccine.2017.05.053","type":"journal-article","created":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T20:00:42Z","timestamp":1496260842000},"page":"3741-3748","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Nontoxic outer membrane vesicles efficiently increase the efficacy of an influenza vaccine in mice and ferrets"],"prefix":"10.1016","volume":"35","author":[{"given":"Sang-Mu","family":"Shim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun-Jung","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daesub","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doo-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong-Hyun","family":"Nam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae","family":"Gwin Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong-Kil","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong-Ki","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.05.053_b0005","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3201\/eid1201.051237","article-title":"Cell-mediated protection in influenza infection","volume":"12","author":"Thomas","year":"2006","journal-title":"Emerg. Infect Dis."},{"key":"10.1016\/j.vaccine.2017.05.053_b0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.immuni.2005.12.005","article-title":"Development of effective vaccines against pandemic influenza","volume":"24","author":"Subbarao","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2017.05.053_b0015","first-page":"3273","article-title":"Toward a broadly protective influenza vaccine","volume":"118","author":"Doherty","year":"2008","journal-title":"J Clin Invest."},{"key":"10.1016\/j.vaccine.2017.05.053_b0020","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.0818-9641.2004.01272.x","article-title":"Vaccine adjuvants: current state and future trends","volume":"82","author":"Petrovsky","year":"2004","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.vaccine.2017.05.053_b0025","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.vaccine.2006.08.036","article-title":"Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice","volume":"25","author":"Kreijtz","year":"2007","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2017.05.053_b0030","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.4049\/jimmunol.176.10.6333","article-title":"T cell responses are better correlates of vaccine protection in the elderly","volume":"176","author":"McElhaney","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2017.05.053_b0035","doi-asserted-by":"crossref","first-page":"e76571","DOI":"10.1371\/journal.pone.0076571","article-title":"Enhanced neutralizing antibody titers and Th1 polarization from a novel Escherichia coli derived pandemic influenza vaccine","volume":"8","author":"Skibinski","year":"2013","journal-title":"PloS One."},{"key":"10.1016\/j.vaccine.2017.05.053_b0040","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/CVI.00156-06","article-title":"Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza","volume":"13","author":"Huber","year":"2006","journal-title":"Clin. Vacc. Immunol: CVI"},{"key":"10.1016\/j.vaccine.2017.05.053_b0045","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1111\/j.1365-2958.2009.06731.x","article-title":"Biogenesis of bacterial membrane vesicles","volume":"72","author":"Deatherage","year":"2009","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.vaccine.2017.05.053_b0050","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.bbamem.2009.08.001","article-title":"Structural modifications of outer membrane vesicles to refine them as vaccine delivery vehicles","volume":"1788","author":"Kim","year":"2009","journal-title":"Biochim Biophys Acta."},{"key":"10.1016\/j.vaccine.2017.05.053_b0055","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1128\/IAI.00533-09","article-title":"Virulence, inflammatory potential, and adaptive immunity induced by Shigella flexneri msbB mutants","volume":"78","author":"Ranallo","year":"2010","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2017.05.053_b0060","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.4049\/jimmunol.175.7.4669","article-title":"Molecular basis of reduced potency of underacylated endotoxins","volume":"175","author":"Teghanemt","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2017.05.053_b0065","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.1365-2958.2005.04711.x","article-title":"The lipid A palmitoyltransferase PagP: molecular mechanisms and role in bacterial pathogenesis","volume":"57","author":"Bishop","year":"2005","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.vaccine.2017.05.053_b0070","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1074\/jbc.M708163200","article-title":"PagP activation in the outer membrane triggers R3 core oligosaccharide truncation in the cytoplasm of Escherichia coli O157:H7","volume":"283","author":"Smith","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vaccine.2017.05.053_b0075","doi-asserted-by":"crossref","first-page":"8293","DOI":"10.1016\/j.vaccine.2011.08.102","article-title":"Adjuvant effect of bacterial outer membrane vesicles with penta-acylated lipopolysaccharide on antigen-specific T cell priming","volume":"29","author":"Lee","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.053_b0080","doi-asserted-by":"crossref","first-page":"9321","DOI":"10.1074\/jbc.M600435200","article-title":"Expression cloning and periplasmic orientation of the Francisella novicida lipid A 4'-phosphatase LpxF","volume":"281","author":"Wang","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vaccine.2017.05.053_b0085","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-1759(98)00170-7","article-title":"A statistically defined endpoint titer determination method for immunoassays","volume":"221","author":"Frey","year":"1998","journal-title":"J. immunol. Methods"},{"key":"10.1016\/j.vaccine.2017.05.053_b0090","doi-asserted-by":"crossref","first-page":"11374","DOI":"10.1128\/JVI.01176-08","article-title":"Pathogenicity and vaccine efficacy of different clades of Asian H5N1 avian influenza A viruses in domestic ducks","volume":"82","author":"Kim","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.vaccine.2017.05.053_b0095","first-page":"493","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hygiene"},{"key":"10.1016\/j.vaccine.2017.05.053_b0100","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.virol.2013.10.010","article-title":"Chimeric SV40 virus-like particles induce specific cytotoxicity and protective immunity against influenza A virus without the need of adjuvants","volume":"448","author":"Kawano","year":"2014","journal-title":"Virology."},{"key":"10.1016\/j.vaccine.2017.05.053_b0105","doi-asserted-by":"crossref","first-page":"8270","DOI":"10.1016\/j.vaccine.2007.09.051","article-title":"Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity","volume":"25","author":"Okamoto","year":"2007","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2017.05.053_b0110","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/S0264-410X(01)00292-4","article-title":"Pre-clinical and clinical investigation of the safety of a novel adjuvant for intranasal immunization","volume":"20","author":"Glueck","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.053_b0115","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1086\/507709","article-title":"Cross-protectiveness and immunogenicity of influenza A\/Duck\/Singapore\/3\/97(H5) vaccines against infection with A\/Vietnam\/1203\/04(H5N1) virus in ferrets","volume":"194","author":"Lipatov","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2017.05.053_b0120","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1750-2659.2008.00054.x","article-title":"A vaccine manufacturer's approach to address medical needs related to seasonal and pandemic influenza viruses","volume":"2","author":"Baras","year":"2008","journal-title":"Influenza Other Respir. Viruses"},{"key":"10.1016\/j.vaccine.2017.05.053_b0125","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3201\/eid1201.051043","article-title":"Making better influenza virus vaccines?","volume":"12","author":"Palese","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.vaccine.2017.05.053_b0130","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1586\/erv.11.23","article-title":"MF59 adjuvant: the best insurance against influenza strain diversity","volume":"10","author":"O'Hagan","year":"2011","journal-title":"Exp. Rev. Vacc."},{"key":"10.1016\/j.vaccine.2017.05.053_b0135","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1016\/j.vaccine.2004.03.032","article-title":"Aluminium adjuvants\u2013in retrospect and prospect","volume":"22","author":"Lindblad","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.053_b0140","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-1-4615-1823-5_8","article-title":"Adjuvant properties of aluminum and calcium compounds","volume":"6","author":"Gupta","year":"1995","journal-title":"Pharm. Biotechnol."},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2017.05.053_b0145","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/S0264-410X(02)00169-X","article-title":"Mechanisms of stimulation of the immune response by aluminum adjuvants","volume":"20","author":"HogenEsch","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.053_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-642-71272-2_1","article-title":"The immune response to influenza infection","volume":"128","author":"Ada","year":"1986","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.vaccine.2017.05.053_b0155","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1101\/gad.1299905","article-title":"Bacterial outer membrane vesicles and the host-pathogen interaction","volume":"19","author":"Kuehn","year":"2005","journal-title":"Genes Develop."},{"key":"10.1016\/j.vaccine.2017.05.053_b0160","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1128\/IAI.73.7.4070-4080.2005","article-title":"Characterization of native outer membrane vesicles from lpxL mutant strains of Neisseria meningitidis for use in parenteral vaccination","volume":"73","author":"Fisseha","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2017.05.053_b0165","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/eji.200535493","article-title":"Intranasal immunisation with inactivated RSV and bacterial adjuvants induces mucosal protection and abrogates eosinophilia upon challenge","volume":"36","author":"Etchart","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.vaccine.2017.05.053_b0170","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1016\/j.vaccine.2005.02.021","article-title":"Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis","volume":"23","author":"Norheim","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.053_b0175","doi-asserted-by":"crossref","first-page":"7692","DOI":"10.4049\/jimmunol.179.11.7692","article-title":"Membrane vesicles are immunogenic facsimiles of Salmonella typhimurium that potently activate dendritic cells, prime B and T cell responses, and stimulate protective immunity in vivo","volume":"179","author":"Alaniz","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2017.05.053_b0180","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.vaccine.2016.12.025","article-title":"Outer membrane vesicles harboring modified lipid A moiety augment the efficacy of an influenza vaccine exhibiting reduced endotoxicity in a mouse model","volume":"35","author":"Lee","year":"2017","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2017.05.053_b0185","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.vaccine.2009.01.109","article-title":"Role of lipopolysaccharide in the induction of type I interferon-dependent cross-priming and IL-10 production in mice by meningococcal outer membrane vesicles","volume":"27","author":"Durand","year":"2009","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2017.05.053_b0190","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nri3254","article-title":"Cross-presentation by dendritic cells","volume":"12","author":"Joffre","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.vaccine.2017.05.053_b0195","doi-asserted-by":"crossref","first-page":"10558","DOI":"10.1128\/JVI.00970-07","article-title":"Evaluation of replication and pathogenicity of avian influenza a H7 subtype viruses in a mouse model","volume":"81","author":"Joseph","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.vaccine.2017.05.053_b0200","doi-asserted-by":"crossref","first-page":"e17616","DOI":"10.1371\/journal.pone.0017616","article-title":"A single base-pair change in 2009 H1N1 hemagglutinin increases human receptor affinity and leads to efficient airborne viral transmission in ferrets","volume":"6","author":"Jayaraman","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2017.05.053_b0205","doi-asserted-by":"crossref","first-page":"e13768","DOI":"10.1371\/journal.pone.0013768","article-title":"Determinants of glycan receptor specificity of H2N2 influenza A virus hemagglutinin","volume":"5","author":"Viswanathan","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2017.05.053_b0210","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1128\/JVI.02885-12","article-title":"Tropism and infectivity of influenza virus, including highly pathogenic avian H5N1 virus, in ferret tracheal differentiated primary epithelial cell cultures","volume":"87","author":"Zeng","year":"2013","journal-title":"J. Virol."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17306898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17306898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T06:11:19Z","timestamp":1569391879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17306898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":42,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0264410X17306898"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.05.053","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nontoxic outer membrane vesicles efficiently increase the efficacy of an influenza vaccine in mice and ferrets","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.05.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}